Robbins Farley raised its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 14.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 25,097 shares of the financial services provider’s stock after purchasing an additional 3,158 shares during the period. iShares Biotechnology […]
John G Ullman & Associates Inc. cut its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 38.2% during the 4th quarter, HoldingsChannel.com reports. The fund owned 1,700 shares of the financial services provider’s stock after selling 1,050 shares during the period. John G Ullman & Associates Inc.’s holdings in iShares Biotechnology ETF were […]
John G Ullman & Associates Inc. decreased its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 38.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,700 shares of the financial services provider’s stock after selling 1,050 shares during the quarter. […]
Sandy Spring Bank raised its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 1.3% in the 4th quarter, Holdings Channel reports. The firm owned 30,566 shares of the financial services provider’s stock after purchasing an additional 397 shares during the quarter. Sandy Spring Bank’s holdings in iShares Biotechnology ETF were worth […]
Carmichael Hill & Associates Inc. increased its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 52.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 608 shares of the financial services provider’s stock after buying an additional 209 shares during the period. Carmichael Hill & Associates Inc.’s holdings in iShares Biotechnology ETF were […]